A research team led by a Medical University of South Carolina (MUSC) investigator reports in the May 6 issue of the New England Journal of Medicine that a four-month treatment regimen using rifapentine is effective for treating TB. Shortening the treatment duration is an important step toward increased patient adherence. Read here
top of page
Recent Posts
See AllJohn Green’s new book Everything is Tuberculosis is scheduled to be published in Spring 2025. The novel laces the experiences of Henry, a...
110
The SIILTIBCY test is now available worldwide through the STOP TB GDF for $1.50 per dose. This novel testing option provides an...
80
The WHO has released the 2024 Global Tuberculosis Report and it places TB as the leading infectious disease killer, surpassing COVID-19....
150
bottom of page
Comentários